stryker corp (SYK:New York)
Transactions by STRYKER CORP (SYK) in the last 6 months
Mariel Therapeutics, Inc. entered into a definitive agreement to acquire Bone Morphogenetic Protein-7 Assets of Stryker Corporation (NYSE:SYK) on July 7, 2014.
Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire the assets of Small Bone Innovations, Inc. from Trevi Health Ventures LP, Viscogliosi Brothers LLC, NGN BioMed Opportunity I, L.P., fund of NGN Capital, 3i Group plc, Axiom Venture Partners LP, GS –goldman sanches Capital Partners, Xeraya Capital Sdn Bhd. and others for approximately $380 million in cash on June 30, 2014. The sales of the products acquired by Stryker totaled about $48 million ...
Axiom Venture Partners III, L.P.
Axiom Venture Partners, L.P.
DFJ Esprit Secondaries LLP
Goldman Sachs Group, Merchant Banking Division
HarbourVest Partners, LLC
New Health Capital Partners Fund I LP
New Health Capital Partners LLC
NGN BioMed Opportunity I, L.P.
Trevi Health Ventures LP
Viscogliosi Brothers LLC
Xeraya Capital Sdn Bhd.
Morgan, Lewis & Bockius LLP
Stryker Corporation (NYSE:SYK) acquired CoAlign Innovations Inc. from Alloy Ventures, Inc. and other investors in first quarter of 2014.
|Becton Dickinson and Co||$114.47 USD||+0.18|
|Covidien PLC||$90.75 USD||-0.91|
|Ecolab Inc||$116.10 USD||-0.02|
|Olympus Corp||¥3,880 JPY||+15.00|
|St Jude Medical Inc||$63.05 USD||+0.29|
|View Industry Companies|